Otonomy Company Profile (NASDAQ:OTIC)

About Otonomy

Otonomy logoOtonomy, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics for diseases and disorders of the ear. The Company has developed a technology referred to as sustained-exposure that is designed to deliver drug that is retained in the ear for an extended period of time following a local administration. Its product candidates include OTIPRIO, OTO-104 and OTO-311. The Company's product candidate, OTIPRIO, is used for the treatment of pediatric patients with bilateral otitis media with effusion undergoing tympanostomy tube placement (TTP) surgery. Its product candidate, OTO-104, is a sustained-exposure formulation of the steroid dexamethasone in development for the treatment of Meniere's disease and other inner ear conditions. The Company's product candidate, OTO-311, is a sustained-exposure formulation of the N-Methyl-D-Aspartate (NMDA) receptor antagonist gacyclidine in development for the treatment of tinnitus.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: OTIC
  • CUSIP:
Key Metrics:
  • Previous Close: $17.65
  • 50 Day Moving Average: $17.06
  • 200 Day Moving Average: $15.48
  • 52-Week Range: $10.50 - $31.15
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.19
  • P/E Growth: -0.23
  • Market Cap: $532.47M
  • Outstanding Shares: 30,168,000
  • Beta: 2.93
Profitability:
  • Return on Equity: -42.24%
  • Return on Assets: -40.35%
Debt:
  • Current Ratio: 22.95%
  • Quick Ratio: 22.87%
Additional Links:
Companies Related to Otonomy:

Analyst Ratings

Consensus Ratings for Otonomy (NASDAQ:OTIC) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $30.67 (73.75% upside)

Analysts' Ratings History for Otonomy (NASDAQ:OTIC)
Show:
DateFirmActionRatingPrice TargetDetails
8/15/2016Piper Jaffray Cos.Reiterated RatingOverweight$32.00View Rating Details
5/26/2016WallachBeth CapitalInitiated CoverageBuy$29.00View Rating Details
10/9/2015Bank of America Corp.UpgradeNeutral -> Buy$31.00View Rating Details
8/13/2015JPMorgan Chase & Co.Initiated CoverageHold$30.00View Rating Details
8/10/2015Sanford C. BernsteinUpgradeMarket Perform -> Outperform$30.00View Rating Details
2/4/2015SunTrust Banks Inc.Initiated CoverageBuy$47.00View Rating Details
2/4/2015Cowen and CompanyInitiated CoverageOutperform$55.00View Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for Otonomy (NASDAQ:OTIC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2016        
3/7/2016Q4($0.95)($0.87)ViewListenView Earnings Details
11/10/2015Q315($0.83)($0.57)ViewN/AView Earnings Details
8/12/2015Q116($0.67)($0.52)ViewN/AView Earnings Details
5/12/2015Q115($0.53)($0.52)ViewN/AView Earnings Details
3/18/2015Q415($0.64)($0.46)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Otonomy (NASDAQ:OTIC)
Current Year EPS Consensus Estimate: $-3.76 EPS
Next Year EPS Consensus Estimate: $-3.4 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.79)($0.79)($0.79)
Q2 20161($0.92)($0.92)($0.92)
Q3 20161($0.93)($0.93)($0.93)
Q4 20161($0.96)($0.96)($0.96)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Otonomy (NASDAQ:OTIC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Otonomy (NASDAQ:OTIC)
Insider Ownership Percentage: 17.90%
Institutional Ownership Percentage: 87.13%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/21/2015Carl LebelinsiderSell21,250$28.04$595,850.00View SEC Filing  
12/17/2015Paul E. CayerinsiderSell3,000$29.70$89,100.00View SEC Filing  
12/15/2015David Allen WeberCEOSell5,208$27.25$141,918.00View SEC Filing  
12/14/2015Robert Michael Savel IIinsiderSell5,000$26.00$130,000.00View SEC Filing  
11/30/2015Chau Quang KhuongDirectorSell67,106$28.93$1,941,376.58View SEC Filing  
11/24/2015Orbimed Advisors LlcDirectorSell200,800$28.56$5,734,848.00View SEC Filing  
11/19/2015Chau Quang KhuongDirectorSell138,398$28.62$3,960,950.76View SEC Filing  
11/17/2015Paul E. CayerinsiderSell3,000$28.69$86,070.00View SEC Filing  
11/16/2015David Allen WeberCEOSell5,208$28.57$148,792.56View SEC Filing  
11/13/2015David Allen WeberCEOSell10,416$30.95$322,375.20View SEC Filing  
11/11/2015David Allen WeberCEOSell5,208$24.95$129,939.60View SEC Filing  
11/11/2015Paul E. CayerCFOSell3,000$24.95$74,850.00View SEC Filing  
9/21/2015Carl LebelinsiderSell21,250$24.36$517,650.00View SEC Filing  
9/17/2015Paul E. CayerCFOSell3,000$24.95$74,850.00View SEC Filing  
9/15/2015David Allen WeberCEOSell5,216$24.95$130,139.20View SEC Filing  
9/14/2015Robert Michael Savel IIinsiderSell5,000$23.98$119,900.00View SEC Filing  
6/15/2015Robert Michael Savel IIInsiderSell25,000$23.73$593,250.00View SEC Filing  
8/19/2014A/S NovoInsiderBuy15,690$15.50$243,195.00View SEC Filing  
8/18/2014A/S NovoInsiderBuy171,875$16.00$2,750,000.00View SEC Filing  
8/18/2014Jay LichterDirectorSell50,001$16.00$800,016.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Otonomy (NASDAQ:OTIC)
DateHeadline
kcregister.com logoWatch List: Otonomy, Inc. (NASDAQ:OTIC), OneBeacon Insurance Group, Ltd. (NYSE:OB), KeyCorp. (NYSE:KEY ... - KC Register (NASDAQ:OTIC)
www.kcregister.com - September 21 at 10:44 AM
investornewswire.com logoShares Of Otonomy, Inc. (NASDAQ:OTIC) Expected To Hit $55 - Investor Newswire (NASDAQ:OTIC)
www.investornewswire.com - September 21 at 10:43 AM
News IconOtonomy completes open-label phase 3b study of Otiprio in patients with history of otitis media requiring tympanostomy tubes (NASDAQ:OTIC)
www.pharmabiz.com - September 19 at 11:09 AM
realistinvestor.com logoResearch Analysts Set Otonomy, Inc. (NASDAQ:OTIC)'s Price Target At $39 - RealistInvestor.com (NASDAQ:OTIC)
www.realistinvestor.com - September 16 at 6:27 PM
rttnews.com logoARLZ Gets FDA Nod, ACRX Scores Hat Trick, OTIC On Watch, No Relief For NVAX (NASDAQ:OTIC)
www.rttnews.com - September 16 at 10:07 AM
publicnow.com logoOtonomy Successfully Completes Open-Label Clinical Trial for OTIPRIO® in Patients with History of Otitis Media Requiring Tympanostomy Tubes (NASDAQ:OTIC)
www.publicnow.com - September 15 at 10:06 AM
News IconSell-side is Weighing in on Otonomy, Inc. (NASDAQ:OTIC) Earnings & Targets - Frisco Fastball (NASDAQ:OTIC)
friscofastball.com - September 14 at 6:45 PM
streetinsider.com logoOtonomy (OTIC) to Present OTIPRIO Phase 2 Data in AOE at American Academy of Otolaryngology - StreetInsider.com (NASDAQ:OTIC)
www.streetinsider.com - September 13 at 11:32 AM
finance.yahoo.com logoOtonomy Announces OTIPRIO® Data Presentation and Symposium at American Academy of Otolaryngology - Head and Neck Surgery Foundation Annual Meeting (NASDAQ:OTIC)
finance.yahoo.com - September 13 at 11:32 AM
News IconAnalysts Place Otonomy, Inc. (NASDAQ:OTIC) Under the Lens of the Microscope - Post News (NASDAQ:OTIC)
www.kentuckypostnews.com - September 12 at 6:21 PM
investornewswire.com logoOtonomy, Inc. (NASDAQ:OTIC) Reported An Earnings Surprise Of -5.38 Percent - Investor Newswire (NASDAQ:OTIC)
www.investornewswire.com - September 12 at 6:21 PM
fidaily.com logoOtonomy, Inc. (NASDAQ:OTIC) Trading Down - Insider Trading Activity - Finance Daily (NASDAQ:OTIC)
www.fidaily.com - September 9 at 6:16 PM
finance.yahoo.com logoOtonomy to Present at Baird Global Healthcare Conference (NASDAQ:OTIC)
finance.yahoo.com - September 1 at 9:48 AM
investornewswire.com logoOtonomy, Inc. (NASDAQ:OTIC) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:OTIC)
www.investornewswire.com - August 24 at 9:46 AM
News IconAuris plunges as Keyzilen falls short in phase III tinnitus trial (NASDAQ:OTIC)
www.bioworld.com - August 19 at 9:44 AM
investornewswire.com logoWill Otonomy, Inc. (NASDAQ:OTIC) Hit $55 Price Target? - Investor Newswire (NASDAQ:OTIC)
www.investornewswire.com - August 18 at 9:46 AM
finance.yahoo.com logoEdited Transcript of OTIC earnings conference call or presentation 4-Aug-16 8:30pm GMT (NASDAQ:OTIC)
finance.yahoo.com - August 15 at 7:01 PM
finance.yahoo.com logoOTONOMY, INC. Financials (NASDAQ:OTIC)
finance.yahoo.com - August 12 at 6:50 PM
capitalcube.com logoETF’s with exposure to Otonomy, Inc. : August 11, 2016 (NASDAQ:OTIC)
www.capitalcube.com - August 11 at 7:10 PM
capitalcube.com logoOtonomy, Inc. breached its 50 day moving average in a Bullish Manner : OTIC-US : August 10, 2016 (NASDAQ:OTIC)
www.capitalcube.com - August 10 at 9:48 AM
rttnews.com logoEGLT Gets FDA Panel Nod, NXTM On A High, BDSI Ahead Of Schedule (NASDAQ:OTIC)
www.rttnews.com - August 5 at 9:46 AM
biz.yahoo.com logoOtonomy Inc Earnings Call (Q2 2016) (NASDAQ:OTIC)
biz.yahoo.com - August 5 at 9:46 AM
sg.finance.yahoo.com logoOtonomy reports 2Q loss (NASDAQ:OTIC)
sg.finance.yahoo.com - August 5 at 9:45 AM
twst.com logoOtonomy Inc.: Otonomy Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:OTIC)
www.twst.com - August 4 at 7:08 PM
biz.yahoo.com logoOtonomy Inc Earnings Call scheduled for 4:30 pm ET today (NASDAQ:OTIC)
biz.yahoo.com - August 4 at 7:08 PM
publicnow.com logoOtonomy Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:OTIC)
www.publicnow.com - August 4 at 7:08 PM
publicnow.com logoOtonomy Successfully Completes One-Year, Multiple-Dose Clinical Safety Trial for OTO-104 in Ménière’s Disease Patients (NASDAQ:OTIC)
www.publicnow.com - August 1 at 7:41 AM
finance.yahoo.com logo7:33 am Otonomy announces the successful completion of a one-year, multiple-dose clinical safety trial of OTO-104 in patients with Mnire's disease (NASDAQ:OTIC)
finance.yahoo.com - August 1 at 7:33 AM
publicnow.com logoOtonomy to Report Second Quarter 2016 Financial Results and Provide Corporate Update (NASDAQ:OTIC)
www.publicnow.com - July 28 at 4:58 PM
News IconEquity Roundup: Stock Performance Focus on Otonomy, Inc. (NASDAQ:OTIC) - Press Telegraph (NASDAQ:OTIC)
presstelegraph.com - July 23 at 10:37 AM
News IconOtonomy Incorporated (NASDAQ:OTIC) Short Interest Increased By 11.52% - Press Telegraph (NASDAQ:OTIC)
presstelegraph.com - July 21 at 7:00 PM
News IconOtonomy, Inc. (NASDAQ:OTIC): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:OTIC)
www.engelwooddaily.com - July 21 at 7:00 PM
ftsenews.co.uk logoOtonomy, Inc. (NASDAQ:OTIC) Updated Price Targets - FTSE News (NASDAQ:OTIC)
www.ftsenews.co.uk - July 20 at 9:34 AM
investornewswire.com logoIs $55 Price Target Attainable For Otonomy, Inc. (NASDAQ:OTIC)? - Investor Newswire (NASDAQ:OTIC)
www.investornewswire.com - July 20 at 9:34 AM
capitalcube.com logoOtonomy, Inc. breached its 50 day moving average in a Bearish Manner : OTIC-US : July 20, 2016 (NASDAQ:OTIC)
www.capitalcube.com - July 20 at 8:18 AM
News IconShares Moving Down on the Week: Otonomy, Inc. (NASDAQ:OTIC) - Engelwood Daily (NASDAQ:OTIC)
www.engelwooddaily.com - July 18 at 12:07 PM
fiscalstandard.com logoOtonomy, Inc. (NASDAQ:OTIC) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:OTIC)
www.fiscalstandard.com - July 18 at 12:07 PM
News IconOtonomy, Inc. (NASDAQ:OTIC) Wall Street Analyst Recommendation Outlook - TGP (NASDAQ:OTIC)
telanaganapress.com - July 18 at 12:07 PM
News IconShares Experiencing a Downtrend: Otonomy, Inc. (NASDAQ:OTIC) - TGP (NASDAQ:OTIC)
telanaganapress.com - July 16 at 9:59 AM
News IconIncreased Volatility Noted on Shares of: Otonomy, Inc. (NASDAQ:OTIC) - Engelwood Daily (NASDAQ:OTIC)
www.engelwooddaily.com - July 15 at 5:45 PM
investornewswire.com logoStrong Sell Calls For Otonomy, Inc. (NASDAQ:OTIC) At 0 - Investor Newswire (NASDAQ:OTIC)
www.investornewswire.com - July 13 at 9:38 AM
News IconOtonomy (NASDAQ:OTIC) Institutional Investors Quarterly Sentiment - Press Telegraph (NASDAQ:OTIC)
presstelegraph.com - July 12 at 10:59 AM
News IconOtonomy Incorporated (NASDAQ:OTIC) Short Interest Decreased By 1.64% - Consumer Eagle (NASDAQ:OTIC)
www.consumereagle.com - July 11 at 6:40 PM
News IconWall Street Ratings and Target Price Views on Otonomy, Inc. (NASDAQ:OTIC) - Telanagana Press (NASDAQ:OTIC)
telanaganapress.com - July 11 at 11:22 AM
News IconWere Analysts Bearish Otonomy Inc (NASDAQ:OTIC) This Week? - Press Telegraph (NASDAQ:OTIC)
presstelegraph.com - July 10 at 10:48 AM
fiscalstandard.com logoBroker Outlook For Otonomy, Inc. (NASDAQ:OTIC) - Fiscal Standard (NASDAQ:OTIC)
www.fiscalstandard.com - July 8 at 6:45 PM
News IconCan Otonomy, Inc. (NASDAQ:OTIC) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:OTIC)
www.engelwooddaily.com - July 7 at 6:43 PM
News IconHeightened Volatility Check on: Otonomy, Inc. (NASDAQ:OTIC) - Engelwood Daily (NASDAQ:OTIC)
www.engelwooddaily.com - July 7 at 6:43 PM
News IconOtonomy Incorporated (NASDAQ:OTIC) Short Interest Decreased By 1.64% - Press Telegraph (NASDAQ:OTIC)
presstelegraph.com - July 7 at 6:43 PM
News IconStock Tracking Down This Month; Investor Alert on Otonomy, Inc. (NASDAQ:OTIC) - Engelwood Daily (NASDAQ:OTIC)
www.engelwooddaily.com - July 6 at 11:20 AM

Social

Otonomy (NASDAQ:OTIC) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff